Cellectar Biosciences
CLRB
CLRB
26 hedge funds and large institutions have $23.9M invested in Cellectar Biosciences in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.84% more ownership
Funds ownership: 0.5% → 2.34% (+1.8%)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.74M | |
| 2 | +$3.43M | |
| 3 | +$1.15M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$987K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$850K |
Top Sellers
| 1 | -$57K | |
| 2 | -$31.7K | |
| 3 | -$6.31K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$166 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$85 |